Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
Using Advanced Imaging to Determine the Benefits of Exercise on Cardiovascular Risk in PTSD
Massachusetts General Hospital
10 participants
Feb 1, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to use a non-invasive imaging technique called positron emission tomography/magnetic resonance imaging (PET/MRI) to investigate the effects of exercise on brain activity and arterial (blood vessel) inflammation in people with PTSD symptoms and evidence of or elevated risk for artery disease.
Eligibility
Inclusion Criteria5
- Age 18-65 years
- Trauma exposure
- PTSD symptoms
- Subclinical atherosclerotic CVD (e.g., coronary, cerebrovascular, or peripheral arterial plaque or calcifications on imaging), clinical atherosclerotic CVD (e.g., myocardial infarction or revascularization), or increased risk for atherosclerotic CVD (i.e., \>2 of hypertension, diabetes mellitus, hyperlipidemia, and active smoking)
- Ability to understand and sign informed consent
Exclusion Criteria14
- History of stroke, brain surgery, or seizure
- Use of certain CVD medications (e.g., beta-blockers, high-intensity statins \[e.g., rosuvastatin 20/40 mg and atorvastatin 40/80 mg\], PCSK-9 inhibitors)
- Psychiatric or cardiovascular medication change within 4 weeks (i.e., stable regimen is allowed)
- Unstable blood pressure or cardiac arrhythmia
- Currently in a supervised or graduated exercise program
- Neurological or systemic inflammatory disease/current systemic anti-inflammatory therapy
- Moderate/severe alcohol/substance use disorder
- Current mania/psychosis
- Weight \>300 lbs.
- Claustrophobia
- Pregnancy
- Metal implants
- Uncontrolled hyperglycemia (HgbA1c\>7.5%)
- Subjects who have had significant radiation exposure as part of research (\>2 nuclear tests, computed tomography images, or fluoroscopic procedures) during the preceding 12-months
Interventions
The exercise program will consist of specifically designed activities to place a gradually increasing workload on the cardiovascular system.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07260032